On Monday, Paris-based French drugmaker Sanofi announced plans to invest more than €1 billion at three facilities in France to create new bioproduction capacity.
Life science group Sartorius and biopharmaceutical firm Sanofi are partnering to create a platform for continuous downstream bioprocessing. Sartorius will use its...
Zeta, an Austrian engineering specialist for biopharmaceutical process plants, has acquired a majority stake in Inosim, a German provider of software solutions for the...
Numerous articles have been published within the last years in chemical science and business media (including this one) on the advantages of continuous reactions, aka...
mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...
EuroAPI today announces that its Italian subsidiary, EuroAPI Italy S.R.L., is suspending the production of all APIs (active pharmaceutical ingredients) in Brindisi.
Partex Group, an AI-driven drug discovery company, today announces a collaboration with global pharmaceutical company Sanofi, aimed at using Partex’s AI technology to...
South Korea-based contract development and manufacturing organization (CDMO) SK Bioscience has broken ground on an approximately 4,200 m2 expansion of its L House vaccine...